Study #2017-1059
Qualitative Study on Experiences Related to Anorexia and the Effects of Anamorelin and Placebo in Advanced Non-small-cell Lung Cancer Patients with Anorexia-Cachexia: A Preliminary Study
MD Anderson Study Status
Not Accepting
Treatment Agent
Anamorelin Hydrochloride
Description
This phase II/III trial studies how well anamorelin hydrochloride works in reducing anorexia in patients with non-small cell lung cancer that has spread to other places in the body. Anamorelin hydrochloride may help to improve patients' appetite in order to stop weight loss.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC V8, Stage IIIA Lung Cancer AJCC V8, Stage IIIB Lung Cancer AJCC V8, Stage IIIC Lung Cancer AJCC V8, Stage IV Lung Cancer AJCC V8, Stage IVA Lung Cancer AJCC V8, Stage IVB Lung Cancer AJCC V8
Study phase:
Phase II/III
Physician name:
Sriram Yennu
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.